Abstract
Changes in p53 levels in human colon cancer cells after treatment with a DNA damaging agent explain why some tumor cells survive and suggest combinatorial strategies for improving therapeutic efficacy.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
